Trelegy ellipta 200-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FFASN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,947
Award facts
- Contract value 100% obligated
- $30,946.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,946.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a non-set-aside competitive award issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. Trelegy Ellipta is a combination pharmaceutical used for chronic obstructive pulmonary disease treatment, representing the type of specialty pharmaceutical product that AmerisourceBergen regularly supplies through its federal medical supply agreements.
This delivery order is issued under AmerisourceBergen's prime IDV with DLA valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies an extensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's demonstrated capability to fulfill federal medical supply requirements through competitive procurement is reflected in its consistent receipt of non-set-aside delivery orders across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FFASN?
SPE2DB25FFASN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FFASN worth?
The government has obligated $30,947 on SPE2DB25FFASN.
Is contract SPE2DB25FFASN an order under another contract?
Yes. SPE2DB25FFASN is a delivery order under SPE2DB24D1021, an indefinite delivery contract.
Was contract SPE2DB25FFASN competed?
The extent of competition for SPE2DB25FFASN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award